JPRN-UMIN000019573已完成未知
18F flutemetamol amyloid-beta PET imaging compared with 11CPIB across the spectrum of Alzheimer's disease - 18F flutemetamol and 11CPIB PET imaging across Alzheimer's disease
Shonan-Atsugi hospital0 个研究点目标入组 200 人开始时间: 2015年11月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •AD subjects were older than 56 years, and met the core clinical criteria of the NIA-Alzheimer's Association for probable AD. MCI subjects were older than 56 years, and met the Core Clinical Criteria for MCI proposed by the NIA-Alzheimer's Association. The normal cognitive status of HC subjects was required to be a MMSE score of 28 or greater and a CDR score of 0. All subjects or their caregiver provided written informed consent for participation. Participants were excluded if they had other systemic or brain diseases,including degenerative,vascular, depressive, traumatic, medical comorbidities, mixed disease, or traumatic brain injury.
研究者
相似试验
已完成
Unknown
[18F]-flutemetamol amyloid imaging along the continuum from normal cognitive status to Alzheimer's disease dementia.JPRN-jRCT1091220124Shizuo Hatashita120
已完成
2 期
Florbetapir F18 (18F-AV-45) amyloid positron emission tomography (PET) imaging in focal dementia syndromesFocal dementia syndromes - primary aphasiaMental and Behavioural DisordersMulti-infarct dementiaISRCTN57388990Avid Radiopharmaceuticals Inc. (USA)25
招募中
不适用
Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-FluselenamylAlzheimer DiseaseNCT06439992Washington University School of Medicine60
进行中（未招募）
1 期
oneFocal dementia syndromes - primary aphasiaMedDRA version: 14.1 Level: LLT Classification code 10012292 Term: Dementia of the Alzheimer's type NOS System Organ Class: 10029205 - Nervous system disordersEUCTR2010-023852-10-GBAvid Radiopharmaceuticals, Inc.23
已完成
不适用
18F-Flutemetamol PET/MRI for detection of plaque vulnerability in atherosclerosisarteriosclerosis10003216atherosclerosisNL-OMON47765Medisch Universitair Ziekenhuis Maastricht25